UConn Dermatology is now enrolling patients in a pediatric eczema study
The purpose of this trial is to determine if a new investigational option is safe and effective in treating atopic dermatitis in children. Children who successfully enroll in this study will be asked to participate for up to 30 weeks including screening, study drug administration, and follow-up periods. During this 30-week time frame, participants will also be asked to visit the study site approximately 11 times for planned study procedures.
Who may be eligible?
- Children 6 months to 17 years old
- Clinically diagnosed with Atopic Dermatitis, also known as Eczema, for 1 year
- Those having had a poor or unsatisfactory response using certain topical medications
Other criteria for eligibility apply. Study participants receive study related medical exams and investigational drug at no cost. Compensation for time and travel is available.
More information can be found at ADORABLESTUDY.COM
IRB # W22-312-1
Principal Investigator: Dr Jun Lu, MD, Director of Dermatology Clinical Research
For more information, contact: EKTOR RAFTI, MD at erafti@uchc.edu